Drug profile · INN
simvastatin
SIMVASTATIN
- US status
- approved
- Patents linked
- 6
- News articles
- 0
Quick answer
simvastatin (SIMVASTATIN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11197844
Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer
granted -
US 10813909
Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer
granted -
US 10793884
Methods and materials for making simvastatin and related compounds
granted -
US 9970037
Methods and materials for making simvastatin and related compounds
granted -
US 8951754
Methods and materials for making simvastatin and related compounds
granted -
US 8211664
Methods and materials for making simvastatin and related compounds
granted
Frequently asked questions
What is simvastatin?
simvastatin (SIMVASTATIN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for simvastatin?
SIMVASTATIN is a marketed brand name for simvastatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of simvastatin?
simvastatin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.